VIVUS Inc. to Acquire PANCREAZE Capsules – Shares Skyrocket
Shares of the biopharmaceutical company VIVUS Inc. (NASDAQ:VVUS) skyrocketed on Tuesday after the company announced that they had entered into an agreement to purchase all rights to PANCREAZE (pancrelipase) Delayed-Release Capsules from Janssen Pharmaceuticals, Inc. ... [Read]
Celldex Shares Fall Over 60% After Failed Drug Study
Shares of the biotechnology company Celldex Therapeutics Inc. (NASDAQ:CLDX) have fallen over 60% today after the company announced that its study in Metastatic Triple-negative Breast Cancer failed to reach the targeted endpoint. The phase 2b ... [Read]
Geron Corporation Trading Higher In Anticipation of Johnson&Johnson Q1 Report
The stock market is in full swing, and one of the trending tickers of the day is a small-cap oncology company that has ties to Johnson & Johnson (NYSE:JNJ). Who’s the lucky winner? Well, it’s ... [Read]
Verastem Inc Shares Rise – New Drug Application Accepted by FDA
Shares of the biopharmaceutical company Verastem Inc. (NASDAQ:VSTM) were on the rise on Monday after the company announced that the United States Food and Drug Administration (FDA) had accepted their New Drug Application (NDA) for ... [Read]
Shares of Menlo Therapeutics Plummet By 70%
Shares of the biopharmaceutical company Menlo Therapeutics Inc. (Nasdaq:MNLO) have plummeted by nearly 70%. The loss of share value is due to the company releasing the results of their Phase 2 Trial of ‘Serlopitant’ for ... [Read]
EyeGate Pharmaceuticals – Stock Up Nearly 25%
Shares of Massachusetts-based EyeGate Pharmaceuticals (Nasdaq:EYEG) have gone up nearly 25% after the company announced the enrollment confirmation of the Phase 3 Clinical Study of EGP-437 in Anterior Uveitis. The trial is meant “to assess ... [Read]
InspireMD Announce $5 Million Public Offering, Stocks Dive -40%
Shares in biotechnology firm InspireMD (NYSE:NSPR) have plummeted over -40% today on the news that the company is to release a public offering of 2.8 million shares at $1.75 per share. The company expects to raise ... [Read]
Flex Pharma Shares Dive
Shares of the biotechnology company Flex Pharma, Inc. (Nasdaq:FLKS) have taken a dive today. After closing at $6.73 USD yesterday, Flex Pharma has gone down nearly 21% since the market opened this morning. The company ... [Read]
Geron Corporation Shares Continue to Rise
Geron Corporation shares (NASDAQ:GERN) continue to rise today. The biopharmaceutical company focuses on cancer research, and today surged up to approximately 18.38%. The company released its fourth quarter and annual financial results and this press release on ... [Read]
Flex Pharma Shares Flip-Flop in Today’s Market
Chicago-based biotechnical company Flex Pharma shares, continue to flip-flop today. As of midday, shares went up to almost 2.20%, but then dropped to 0.14% within an hour. The company has been working on creating a ... [Read]